{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:24:16Z","timestamp":1790281456525,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"ANR","award":["ANR-16-CE37-0007-03"],"award-info":[{"award-number":["ANR-16-CE37-0007-03"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.neubiorev.2019.01.008","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T11:10:54Z","timestamp":1547032254000},"page":"164-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Functional imaging studies of Impulse Control Disorders in Parkinson\u2019s disease need a stronger neurocognitive footing"],"prefix":"10.1016","volume":"98","author":[{"given":"Garance M.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Spay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Laurencin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Ballanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Sescousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Boulinguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2019.01.008_bib0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1515\/revneuro-2014-0078","article-title":"Tracking markers of response inhibition in electroencephalographic data: why should we and how can we go beyond the N2 component?","volume":"26","author":"Albares","year":"2015","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brs.2014.09.002","article-title":"Interaction of noradrenergic pharmacological manipulation and subthalamic stimulation on movement initiation control in Parkinson\u2019s disease","volume":"8","author":"Albares","year":"2015","journal-title":"Brain Stimul."},{"issue":"Suppl 1","key":"10.1016\/j.neubiorev.2019.01.008_bib0015","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S1353-8020(13)70005-1","article-title":"Behavioral disorders in Parkinson\u2019s disease: the role of dopamine","volume":"20","author":"Antonelli","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jns.2011.06.006","article-title":"Impulsivity and Parkinson\u2019s disease: more than just disinhibition","volume":"310","author":"Antonelli","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0025","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/hbm.22344","article-title":"Dopamine-agonists and impulsivity in Parkinson\u2019s disease: impulsive choices vs. impulsive actions","volume":"35","author":"Antonelli","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","article-title":"ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson\u2019s disease","volume":"88","author":"Antonini","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.neubiorev.2019.01.008_bib0035","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.parkreldis.2015.08.003","article-title":"Molecular imaging and neural networks in impulse control disorders in Parkinson\u2019s disease","volume":"22","author":"Aracil-Bola\u00f1os","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0040","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ana.21795","article-title":"Stimulation of the subthalamic nucleus and impulsivity: release your horses","volume":"66","author":"Ballanger","year":"2009","journal-title":"Ann. Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.neubiorev.2019.01.008_bib0045","first-page":"347","article-title":"Noradrenergic modulation of movement initiation control in Parkinson\u2019s disease: a pharmacological fMRI study with clonidine [abstract]","volume":"29","author":"Ballanger","year":"2014","journal-title":"Mov. Disord. 2014"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pneurobio.2013.06.005","article-title":"Inhibition and impulsivity: behavioral and neural basis of response control","volume":"108","author":"Bari","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JPD-120165","article-title":"A systematic review of impulse control disorders in Parkinson\u2019s disease","volume":"3","author":"Callesen","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0269881113480988","article-title":"Noradrenergic modulation of cognition: therapeutic implications","volume":"27","author":"Chamberlain","year":"2013","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0065","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/YCO.0b013e3280ba4989","article-title":"The neuropsychiatry of impulsivity","volume":"20","author":"Chamberlain","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0070","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.1121218","article-title":"Neurochemical modulation of response inhibition and probabilistic learning in humans","volume":"311","author":"Chamberlain","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0075","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.biopsych.2008.10.014","article-title":"Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study","volume":"65","author":"Chamberlain","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0080","first-page":"5","article-title":"Compulsive buying: descriptive characteristics and psychiatric comorbidity","volume":"55","author":"Christenson","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00429-011-0314-0","article-title":"Impulse control disorders in Parkinson\u2019s disease: seeking a roadmap toward a better understanding","volume":"216","author":"Cilia","year":"2011","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","article-title":"Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling","volume":"39","author":"Cilia","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s13311-013-0238-x","article-title":"Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson\u2019s disease","volume":"11","author":"Connolly","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0100","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005816","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease","author":"Corvol","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neubiorev.2012.11.003","article-title":"Have we been asking the right questions when assessing response inhibition in go\/no-go tasks with fMRI? A meta-analysis and critical review","volume":"37","author":"Criaud","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fpsyg.2012.00059","article-title":"Proactive inhibitory control of response as the default state of executive control","volume":"3","author":"Criaud","year":"2012","journal-title":"Front. Psychol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3233\/JPD-150750","article-title":"Slowness in movement initiation is associated with proactive inhibitory network dysfunction in parkinson\u2019s disease","volume":"6","author":"Criaud","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2017.06.030","article-title":"Testing the physiological plausibility of conflicting psychological models of response inhibition: a forward inference fMRI study","author":"Criaud","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1741-7015-11-126","article-title":"Toward the future of psychiatric diagnosis: the seven pillars of RDoC","volume":"11","author":"Cuthbert","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrn.2017.8","article-title":"Fractionating impulsivity: neuropsychiatric implications","volume":"18","author":"Dalley","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2011.01.020","article-title":"Impulsivity, compulsivity, and top-down cognitive control","volume":"69","author":"Dalley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.euroneuro.2018.03.012","article-title":"Neurocognitive correlates of medication-induced addictive behaviours in Parkinson\u2019s disease: a systematic review","volume":"28","author":"Dawson","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0145","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0150","doi-asserted-by":"crossref","first-page":"12444","DOI":"10.1523\/JNEUROSCI.1458-14.2014","article-title":"Three mechanisms by which striatal denervation causes breakdown of dopamine signaling","volume":"34","author":"Dreyer","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0155","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-008-1127-6","article-title":"The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go\/no-go tasks","volume":"199","author":"Eagle","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0160","first-page":"25","article-title":"Aberrant decision-making and drug addiction\u2014how strong is the evidence? Current Opinion in Behavioral Sciences","volume":"13","author":"Ekhtiari","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1092852913000801","article-title":"New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity","volume":"19","author":"Fineberg","year":"2014","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0170","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s40265-013-0105-4","article-title":"Non-dopaminergic treatments for motor control in Parkinson\u2019s disease","volume":"73","author":"Fox","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0175","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1474-4422(08)70214-X","article-title":"Non-dopaminergic treatments in development for Parkinson\u2019s disease","volume":"7","author":"Fox","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0180","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/mds.23369","article-title":"Parkinson\u2019s disease and pathological gambling: results from a functional MRI study","volume":"25","author":"Frosini","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0185","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mds.25679","article-title":"Alexithymia-an independent risk factor for impulsive-compulsive disorders in Parkinson\u2019s disease","volume":"29","author":"Goerlich-Dobre","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0190","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JPD-140351","article-title":"Impulse control disorders are associated with multiple psychiatric symptoms in Parkinson\u2019s disease","volume":"4","author":"Jaakkola","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0195","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainres.2007.08.032","article-title":"Cueing method biases in visual detection studies","volume":"1179","author":"Jaffard","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0200","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.neuroimage.2008.05.041","article-title":"Proactive inhibitory control of movement assessed by event-related fMRI","volume":"42","author":"Jaffard","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0205","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.07.010","article-title":"Dyskinesias and impulse control disorders in Parkinson\u2019s disease: from pathogenesis to potential therapeutic approaches","volume":"56","author":"Jim\u00e9nez-Urbieta","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0210","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mds.24941","article-title":"Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders","volume":"27","author":"Joutsa","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0215","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/brain\/awu117","article-title":"Targeting impulsivity in Parkinson\u2019s disease using atomoxetine","volume":"137","author":"Kehagia","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0220","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.joep.2012.03.007","article-title":"Towards an incentive salience model of intertemporal choice","volume":"33","author":"Lades","year":"2012","journal-title":"J. Econ. Psychol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/jnnp-2013-305549","article-title":"Extrastriatal dopaminergic changes in Parkinson\u2019s disease patients with impulse control disorders","volume":"85","author":"Lee","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0230","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00213-011-2550-7","article-title":"Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity","volume":"219","author":"Leeman","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0235","doi-asserted-by":"crossref","first-page":"13892","DOI":"10.1073\/pnas.1518285112","article-title":"Why significant variables aren\u2019t automatically good predictors","volume":"112","author":"Lo","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0240","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature06976","article-title":"What we can do and what we cannot do with fMRI","volume":"453","author":"Logothetis","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0245","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-018-1870-8","article-title":"Impulse control disorders in Parkinson\u2019s disease","author":"Marques","year":"2018","journal-title":"J. Neural Transm. Vienna (Vienna)"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0250","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mds.26068","article-title":"Linking neuroscience with modern concepts of impulse control disorders in Parkinson\u2019s disease","volume":"30","author":"Napier","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085747","article-title":"Multiple modes of impulsivity in Parkinson\u2019s disease","volume":"9","author":"Nombela","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0260","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/brain\/awr003","article-title":"Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behaviours","volume":"134","author":"O\u2019Sullivan","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0265","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1017\/S1461145711001635","article-title":"Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat","volume":"15","author":"Paterson","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0270","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0275","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mds.26135","article-title":"[11C]-(+)-PHNO PET imaging of dopamine D(2\/3) receptors in Parkinson\u2019s disease with impulse control disorders","volume":"30","author":"Payer","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0280","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/brain\/aws326","article-title":"Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson\u2019s disease","volume":"136","author":"Politis","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0285","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.parkreldis.2016.05.028","article-title":"Impulse control disorder in PD: a lateralized monoaminergic frontostriatal disconnection syndrome?","volume":"30","author":"Premi","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0290","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11910-013-0386-8","article-title":"The functional anatomy of impulse control disorders","volume":"13","author":"Probst","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0295","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/brain\/aww138","article-title":"Atomoxetine restores the response inhibition network in Parkinson\u2019s disease","volume":"139","author":"Rae","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0300","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/mds.23147","article-title":"Decreased ventral striatal activity with impulse control disorders in Parkinson\u2019s disease","volume":"25","author":"Rao","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0305","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00702-012-0933-5","article-title":"Imaging impulse control disorders in Parkinson\u2019s disease and their relationship to addiction","volume":"120","author":"Ray","year":"2013","journal-title":"J. Neural Transm. Vienna (Vienna)"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0310","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","article-title":"Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson\u2019s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study","volume":"48","author":"Ray","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0315","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1111\/bph.13826","article-title":"Cross-species studies of cognition relevant to drug discovery: a translational approach","volume":"174","author":"Robbins","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0320","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.051508.135535","article-title":"The neuropsychopharmacology of fronto-executive function: monoaminergic modulation","volume":"32","author":"Robbins","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0325","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tics.2011.11.009","article-title":"Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry","volume":"16","author":"Robbins","year":"2012","journal-title":"Trends Cogn. Sci. (Regul. Ed.)"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0330","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mds.26099","article-title":"Management of impulse control disorders in Parkinson\u2019s disease: controversies and future approaches","volume":"30","author":"Samuel","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0335","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neubiorev.2017.02.018","article-title":"The relationship between impulse control disorders and cognitive dysfunctions in parkinson\u2019s disease: a meta-analysis","volume":"77","author":"Santangelo","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0340","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neubiorev.2013.02.002","article-title":"Processing of primary and secondary rewards: a quantitative meta-analysis and review of human functional neuroimaging studies","volume":"37","author":"Sescousse","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0345","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrn3137","article-title":"Spectral fingerprints of large-scale neuronal interactions","volume":"13","author":"Siegel","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0350","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","article-title":"Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease","volume":"87","author":"Smith","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0355","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.14447","article-title":"Clonidine modulates the activity of the subthalamic-supplementary motor loop: evidence from a pharmacological study combining DBS and EEG recordings in Parkinsonian patients","author":"Spay","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0360","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/brain\/awp054","article-title":"Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study","volume":"132","author":"Steeves","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0365","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40429-014-0036-5","article-title":"Models of impulsivity with a focus on waiting impulsivity: translational potential for neuropsychiatric disorders","volume":"1","author":"Voon","year":"2014","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0370","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuron.2009.12.027","article-title":"Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors","volume":"65","author":"Voon","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0375","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jnnp-2013-305395","article-title":"Impulse control disorders in Parkinson\u2019s disease: decreased striatal dopamine transporter levels","volume":"85","author":"Voon","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0380","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","article-title":"Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update","volume":"16","author":"Voon","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0385","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-017-2771-0","article-title":"The neurobiology of impulse control disorders in Parkinson\u2019s disease: from neurotransmitters to neural networks","author":"Vriend","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0390","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.25886","article-title":"Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease","volume":"29","author":"Vriend","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0395","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neubiorev.2013.11.001","article-title":"Depression and impulse control disorders in Parkinson\u2019s disease: two sides of the same coin?","volume":"38","author":"Vriend","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0400","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1111\/j.1460-9568.2012.08264.x","article-title":"Proactive inhibitory control varies with task context","volume":"36","author":"Wardak","year":"2012","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl 2","key":"10.1016\/j.neubiorev.2019.01.008_bib0405","first-page":"S93","article-title":"Dopamine and impulse control disorders in Parkinson\u2019s disease","volume":"64","author":"Weintraub","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0410","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","article-title":"Impulse control and related disorders in parkinson\u2019s disease","volume":"133","author":"Weintraub","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0415","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0420","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0425","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.26016","article-title":"Clinical spectrum of impulse control disorders in Parkinson\u2019s disease","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0430","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s00415-015-7722-7","article-title":"Single versus multiple impulse control disorders in Parkinson\u2019s disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release","volume":"262","author":"Wu","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0435","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.biopsych.2014.01.024","article-title":"Improving response inhibition in Parkinson\u2019s disease with atomoxetine","volume":"77","author":"Ye","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.01.008_bib0440","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hbm.23087","article-title":"Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson\u2019s disease with clinical and neuroimaging measures","volume":"37","author":"Ye","year":"2016","journal-title":"Hum. Brain Mapp."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976341830469X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976341830469X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:26:32Z","timestamp":1758965192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014976341830469X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":88,"alternative-id":["S014976341830469X"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.01.008","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional imaging studies of Impulse Control Disorders in Parkinson\u2019s disease need a stronger neurocognitive footing","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}